Quinagolide clinical trials
Also written FE 999051.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How each study uses quinagolide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2006 (1)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2018 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 1
Ferring Pharmaceuticals (3) · Instituto Valenciano de Infertilidad, IVI VALENCIA (1)
Related medicines
As reviewed, each with the page that says it.
- One of Dopamine agonists source
Studies
Open first, then newest update. How each study uses quinagolide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related PainCompletedPhase 2Ferring PharmaceuticalsNCT03692403Written as Quinagolide 360 µgHow we know
- Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/AdenomyosisCompletedPhase 2Ferring PharmaceuticalsNCT03749109Written as Quinagolide 1080 µgHow we know
- Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of QuinagolideCompletedPhase 2Ferring PharmaceuticalsNCT00329693Written as NorprolacHow we know
- Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation SyndromeCompletedPhase 2Instituto Valenciano de Infertilidad, IVI VALENCIANCT00665041Written as QuinagolideHow we know
Codes
What other systems call quinagolide · ClinicalTrials.gg INT003237
- MeSH (NLM) C046650quinagolideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 80Q9QWN15MQUINAGOLIDEConfirmed FDA, NLM, Wikidata
- RxNorm 76887Confirmed FDA, Wikidata
- Wikidata Q4860568QuinagolideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C73310QuinagolideOne source FDA
- DrugBank DB09097One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C046650 | quinagolide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 80Q9QWN15M | QUINAGOLIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 76887 | — | Confirmed FDA, Wikidata |
| Wikidata | Q4860568 | Quinagolide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C73310 | Quinagolide | One source FDA |
| DrugBank | DB09097 | — | One source Wikidata |
Also registered as quinagolide hydrochloride (UNII 33474X943Y · RxNorm 236233).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.